Log In
Print
BCIQ
Print
Print this Print this
 

LY2605541

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionBasal insulin analog
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase III
Standard IndicationDiabetes
Indication DetailsTreat Type I diabetes; Treat Type II diabetes
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today